Opiant Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Opiant Pharmaceuticals's estimated annual revenue is currently $4.8M per year.
- Opiant Pharmaceuticals's estimated revenue per employee is $201,000
Employee Data
- Opiant Pharmaceuticals has 24 Employees.
- Opiant Pharmaceuticals grew their employee count by -59% last year.
Opiant Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | EVP, Corporate Development and General Counsel | Reveal Email/Phone |
2 | VP Communications and Investor Relations | Reveal Email/Phone |
3 | Associate Director, Project Management | Reveal Email/Phone |
4 | Drug Development Associate Director | Reveal Email/Phone |
5 | Chief Development Officer | Reveal Email/Phone |
6 | Chief Commercial Officer | Reveal Email/Phone |
7 | Associate Director, Project Management | Reveal Email/Phone |
8 | Director, Supply Chain | Reveal Email/Phone |
9 | Clinical Trial Manager | Reveal Email/Phone |
10 | Clinical Trial Manager | Reveal Email/Phone |
Opiant Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $46.2M | 230 | 5% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $24.5M | 122 | 3% | N/A | N/A |
#5 | $52.9M | 263 | 13% | N/A | N/A |
#6 | $24.7M | 123 | 13% | N/A | N/A |
#7 | $1.8M | 18 | 0% | $114.3M | N/A |
#8 | $7.2M | 36 | -20% | N/A | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $7.6M | 39 | -13% | $123.9M | N/A |
What Is Opiant Pharmaceuticals?
Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose. Stay up to date with news on business news, results, and product innovation updates by following our page and visiting our site www.Opiant.com
keywords:N/A
N/A
Total Funding
24
Number of Employees
$4.8M
Revenue (est)
-59%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Opiant Pharmaceuticals News
2022-04-17 - Opiant Pharmaceuticals (NASDAQ:OPNT) Stock Rating ...
Opiant Pharmaceuticals, Inc is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and...
2022-03-22 - Opiant Pharmaceuticals Announces Fourth Quarter and Full ...
About Opiant Pharmaceuticals, Inc. Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise...
Other Companies in Santa Monica
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4.5M | 24 | 9% | N/A |
#2 | N/A | 24 | -4% | N/A |
#3 | $3M | 24 | 4% | $21M |
#4 | $2.8M | 24 | 9% | N/A |
#5 | $4.5M | 24 | -17% | N/A |